Always up to date.

Merz Therapeutics announces today the appointment of Leonard Paolillo as President, Merz Therapeutics North America, effective immediately. In this role, Leonard will join the Global Therapeutics...

Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA (fampridine) expands specialty neurology portfolio. Lays groundwork for Parkinson’s disease franchise and anchor in multiple...

At Merz Therapeutics, diversity, equity and inclusion are woven into the fabric of our organization. As part of Women’s History Month this March, we sat down with Althea Danzey, Senior Director,...

Merz Therapeutics announced today that is has earned the Great Place to Work^® CertificationTM for both its United States (U.S.) and Canada businesses. Great Place To Work is the global...

Dive into an inspiring conversation with Kevin Walker, head of the LGBTQIA+ advocacy group at Merz Therapeutics in North America. Explore his personal journey and impactful initiatives fostering...

Merz Therapeutics announced today the presentation of data from 10 accepted abstracts on XEOMIN^® (incobotulinumtoxinA) at TOXINS 2022: Basic Science and Clinical Aspects of Botulinum...